These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 3285477)
41. Combined-modality therapy of rectal cancer with irinotecan-based regimens. Minsky BD Oncology (Williston Park); 2004 Dec; 18(14 Suppl 14):49-55. PubMed ID: 15685836 [TBL] [Abstract][Full Text] [Related]
42. Chemoradiotherapy for rectal cancer: current status and perspectives. Watanabe T; Kiyomatsu T; Kanazawa T; Tada T; Komuro Y; Tsurita G; Muto T; Nagawa H Int J Clin Oncol; 2004 Dec; 9(6):475-83. PubMed ID: 15616878 [No Abstract] [Full Text] [Related]
43. Ileostomy dysfunction with adjuvant chemoradiation for rectal carcinoma requiring in-hospital management: a cause for concern. Chen FC; Mackay JR; Woods RJ Aust N Z J Surg; 1996 Sep; 66(9):641-2. PubMed ID: 8859169 [TBL] [Abstract][Full Text] [Related]
44. [Adjuvant and neoadjuvant radiochemotherapy of rectal carcinoma]. Sauer R; Rödel C Praxis (Bern 1994); 2002 Sep; 91(37):1476-84. PubMed ID: 12360683 [TBL] [Abstract][Full Text] [Related]
45. Adjuvant therapy for resectable rectal and colonic cancer. Heriot AG; Kumar D Br J Surg; 1998 Mar; 85(3):300-9. PubMed ID: 9529480 [TBL] [Abstract][Full Text] [Related]
46. [Value of postoperative adjuvant chemotherapy in locally advanced rectal cancer patients with ypT1-4N0 after neo-adjuvant chemoradiotherapy]. You KY; Peng HH; Gao YH; Chen L; Zhou GQ; Chang H; Du XJ; Xiao L; Zeng ZF; Wen BX; Liu MZ Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):708-13. PubMed ID: 24332061 [TBL] [Abstract][Full Text] [Related]
47. [Advance in preoperative radiochemotherapy for resectable rectal cancer]. Chen YH; Li ZP Ai Zheng; 2008 Dec; 27(12):1341-4. PubMed ID: 19080006 [TBL] [Abstract][Full Text] [Related]
48. [Choice of treatment in rectal cancer. Consensus Conference, Chamber of Commerce and Industry, Paris, December 1-2, 1994]. Ann Gastroenterol Hepatol (Paris); 1995 Sep; 31(4):226-30, 233-6. PubMed ID: 7486820 [No Abstract] [Full Text] [Related]
49. [A case of advanced rectal carcinoma, preoperative chemo-radiation therapy leading to histological complete response]. Ishigami S; Kato K; Baba K; Onohara S; Hatanaka S; Aridome K; Okumura H; Matsumoto M; Natsugoe S; Aikou T Gan To Kagaku Ryoho; 2006 Sep; 33(9):1345-8. PubMed ID: 16969039 [TBL] [Abstract][Full Text] [Related]
50. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade. Wheeler JM; Dodds E; Warren BF; Cunningham C; George BD; Jones AC; Mortensen NJ Dis Colon Rectum; 2004 Dec; 47(12):2025-31. PubMed ID: 15657650 [TBL] [Abstract][Full Text] [Related]
51. Combined-modality therapy for rectal cancer using irinotecan. Minsky BD Oncology (Williston Park); 2002 May; 16(5 Suppl 5):35-8. PubMed ID: 12109805 [TBL] [Abstract][Full Text] [Related]
52. Role of pelvic radiotherapy for locally advanced rectal cancer and synchronous unresectable distant metastases. Liu KT; Wan JF; Zhu J; Li GC; Sun WJ; Shen LJ; Cai SJ; Gu WL; Lian P; Zhang Z Cancer Radiother; 2016 Dec; 20(8):805-810. PubMed ID: 27777027 [TBL] [Abstract][Full Text] [Related]
53. Beyond 5-fluorouracil: the emerging role of newer chemotherapeutics and targeted agents with radiation therapy. Czito BG; Willett CG Semin Radiat Oncol; 2011 Jul; 21(3):203-11. PubMed ID: 21645865 [TBL] [Abstract][Full Text] [Related]
54. Infusional 5-fluorouracil and ZD1839 (Gefitinib-Iressa) in combination with preoperative radiotherapy in patients with locally advanced rectal cancer: a phase I and II Trial (1839IL/0092). Valentini V; De Paoli A; Gambacorta MA; Mantini G; Ratto C; Vecchio FM; Barbaro B; Innocente R; Rossi C; Boz G; Barba MC; Frattegiani A; Lupattelli M; Doglietto GB Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):644-9. PubMed ID: 18395356 [TBL] [Abstract][Full Text] [Related]
55. Advanced moderately differentiated neuroendocrine carcinoma of the rectum with favorable prognosis by postoperative chemoradiation. Nojima H; Seike K; Kosugi C; Shida T; Koda K; Oda K; Kamata S; Ishikura H; Miyazaki M World J Surg Oncol; 2010 Apr; 8():29. PubMed ID: 20398400 [TBL] [Abstract][Full Text] [Related]
56. [Chemoradiation for rectal cancer]. Koyanagi Y; Katoh K; Satoh S Gan To Kagaku Ryoho; 1997 Nov; 24(14):2078-83. PubMed ID: 9388516 [TBL] [Abstract][Full Text] [Related]
57. Surgical therapy of early rectal carcinoma. Curley SA; Roh MS; Rich TA Hematol Oncol Clin North Am; 1989 Mar; 3(1):87-102. PubMed ID: 2645273 [TBL] [Abstract][Full Text] [Related]
58. Recent advances in the treatment of rectal carcinoma. Watanabe T; Muto T Crit Rev Oncol Hematol; 1999 Sep; 32(1):5-17. PubMed ID: 10586351 [No Abstract] [Full Text] [Related]
59. [Intraoperative radiotherapy as multimodal therapy approach in epithelial tumors of the gastrointestinal system]. Brüwer M; Hesselmann S; Schäfer U; Willich N; Senninger N Chirurg; 2000 Jun; 71(6):682-91. PubMed ID: 10948735 [TBL] [Abstract][Full Text] [Related]
60. Adjuvant treatment in the curative management of rectal cancer: a critical review of the results of clinical randomised trials. Bosset JF; Horiot JC Eur J Cancer; 1993; 29A(5):770-4. PubMed ID: 8471338 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]